Epa and dha enriched omega-3 supplement for the treatment of dry eye, meibomianitis and xerostomia
CA 2491710 A1 · Owner: Advanced Vision Research · Inventors: Gilbard, Jeffrey, P.
Overview
Its claims, description and drawings are in the Canadian Patents Database.
Open the CIPO recordAbstract From the Canadian patent
Nutritional supplements for treating dry eye meibomian gland inflammation, meibomian gland dysfunction or xerostomia comprising flaxseed oil or a GLA-, rich oil, combined with a n-3 rich oil such as fish oil which is rich in , eicosapentaenoic acid (EPA) and docosahexaeonic acid (DHA) are disclosed. , Methods of treating dry eye meibomian gland inflammation, meibomian gland dysfunction or dry mouth by administering the supplements are also described.
Read the whole patent
Listed from its CIPO record in Patent Yard's archive of Canadian patents past their term. Its claims, description and drawings are in the CIPO record and on Google Patents, and the Claude kit works from them.
Why it's free to use
- Filed July 8, 2003. No grant is recorded for it in Canada; had it been granted, its 20-year term would have ended July 8, 2023.
- A certificate of supplementary protection adds at most two years for a drug, so even that would have ended by July 8, 2025.
- We check Canadian rights only. A patent in its family in another country could still be in force: check its family on Google Patents.
Timeline
Timeline From CIPO dates
Sources & verification
Official CIPO records
Everything on this page comes from the CIPO record linked above. Contains information licensed under the Open Government Licence – Canada.